David M. Stark
Executive Vice President, Chief Legal Officer
David Stark became Executive Vice President (EVP), Chief Legal Officer in November 2017.
The global Legal Group works hand in hand with Teva’s senior management and its various business units to provide legal advice for the company’s ongoing undertakings, ensuring adherence to applicable laws and regulations in the jurisdictions where Teva conducts its business. Its focus is primarily corporate governance, transactions and intellectual property matters.
Since joining Teva in 2002, David has served in a series of roles with increasing responsibilities in Teva North America and Teva Americas, including as Senior Director, Deputy General Counsel, and Vice President and General Counsel.
Prior to joining Teva, he was an associate attorney in the litigation departments at Willkie Farr & Gallagher LLP, Chadbourne & Parke and Haight, Gardner, Poor & Havens.
David received a J.D. from New York University School of Law and a B.A. in political science from Northeastern University, summa cum laude.
Richard Francis
President and Chief Executive Officer, Member of the Board of Directors
Richard Daniell
Executive Vice President, European Commercial
Dr. Sven Dethlefs
Executive Vice President, North America Commercial
Eric Drapé
Executive Vice President, Global Operations
Dr. Eric A. Hughes
Executive Vice President, Global R&D and Chief Medical Officer
Galia Inbar
Executive Vice President, Chief Human Resources Officer and Corporate Affairs
Eli Kalif
Executive Vice President, Chief Financial Officer (CFO)
Mark Sabag
Executive Vice President, International Markets Commercial
Dr. Angus Grant, Ph.D.
Executive Vice President, Business Development
Nir Baron
Senior Vice President, Chief Internal Auditor
Kathleen Veit
Senior Vice President, Global Compliance & Ethics Officer
